Blood and Immunity Practice Questions

Q: Neonatal thymectomy leads to what immunological change?

Decreased size of paracortical areas. ### Explanation The thymus is the primary lymphoid organ responsible for the maturation and differentiation of **T-lymphocytes**. In the lymph nodes, these T-cells specifically colonize the **paracortical area** (the zone between the cortex and the medulla). **1. Why Option B is Correct:** Neonatal thymectomy removes the source of mature T-cells before they can seed peripheral lymphoid organs. Since the paracortex of the lymph node (and the periarteriolar lymphoid sheaths or PALS in the spleen) is **T-cell dependent**, the absence of T-cells leads to lymphoid depletion in these specific zones, resulting in a decreased size of the paracortical areas. **2. Why Other Options are Incorrect:** * **Option A:** Germinal centers are located in the lymphoid follicles of the outer cortex and are **B-cell dependent** areas. Thymectomy primarily affects cell-mediated immunity, not the primary architecture of B-cell zones. * **Option C:** Antibody production is a function of B-cells (plasma cells). While T-helper cells assist in class switching, a thymectomy would generally lead to *decreased* or impaired antibody responses to T-dependent antigens, never an increase. * **Option D:** Bone marrow is the site of lymphopoiesis (production). Thymectomy affects the *maturation* of T-cells, not the initial production of lymphoid progenitors in the bone marrow. ### High-Yield Clinical Pearls for NEET-PG: * **T-cell Dependent Zones:** Paracortex (Lymph node), PALS (Spleen). * **B-cell Dependent Zones:** Germinal centers/Follicles (Lymph node and Spleen). * **DiGeorge Syndrome:** A clinical "human model" of neonatal thymectomy (congenital thymic aplasia) characterized by T-cell deficiency and paracortical atrophy. * **Hassall’s Corpuscles:** Characteristic epithelial structures found in the thymic medulla; their presence is a key histological marker for the thymus.

Q: Which of the following is likely to be increased in vitamin K deficiency?

PT. ### Explanation **Vitamin K** is a vital cofactor for the enzyme **gamma-glutamyl carboxylase**, which is responsible for the post-translational modification (gamma-carboxylation) of clotting factors **II, VII, IX, and X**, as well as proteins C and S. This process allows these factors to bind calcium and phospholipid membranes, making them functional. **Why PT is the correct answer:** Prothrombin Time (PT) measures the **extrinsic and common pathways**. Factor **VII** (extrinsic pathway) has the shortest half-life (approx. 6 hours) among all clotting factors. Consequently, when Vitamin K is deficient, Factor VII levels drop first, making **PT the most sensitive and earliest laboratory indicator** of Vitamin K deficiency or early warfarin therapy. **Analysis of Incorrect Options:** * **PTT (Partial Thromboplastin Time):** While PTT measures the intrinsic pathway (including Vitamin K-dependent factors IX, X, and II) and *can* be prolonged in severe or prolonged deficiency, it is not as sensitive or as early an indicator as PT. * **Platelet Count:** Vitamin K deficiency affects the coagulation cascade (secondary hemostasis), not platelet production or number (primary hemostasis). * **Fibrinogen Time (Thrombin Time):** This measures the conversion of fibrinogen to fibrin. Fibrinogen (Factor I) is not Vitamin K-dependent; therefore, this remains normal. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic:** Remember **"1972"** for Vitamin K-dependent factors (Factors **10, 9, 7, 2**). * **Warfarin:** Acts as a Vitamin K antagonist; PT/INR is used to monitor its therapeutic effect. * **Hemorrhagic Disease of the Newborn:** Neonates are Vitamin K deficient due to sterile guts and poor placental transfer; hence, prophylactic Vitamin K is given at birth. * **Absorption:** Vitamin K is fat-soluble; deficiency can occur in malabsorption syndromes (e.g., Celiac disease) or obstructive jaundice.

Q: Regarding hemostasis, what is the true statement for nitric oxide?

Inhibits platelet aggregation. ### Explanation Nitric Oxide (NO), formerly known as Endothelium-Derived Relaxing Factor (EDRF), is a key gaseous signaling molecule produced by vascular endothelial cells. **Why Option D is Correct:** Nitric oxide plays a crucial role in maintaining vascular patency and preventing intravascular thrombosis. It diffuses into platelets and activates **soluble guanylyl cyclase**, which increases intracellular levels of **cyclic GMP (cGMP)**. Elevated cGMP leads to a decrease in intracellular calcium levels, which effectively **inhibits platelet adhesion and aggregation**. This ensures that the clotting process is localized only to the site of vascular injury and not spread across healthy endothelium. **Analysis of Incorrect Options:** * **Option A:** NO is a potent **vasodilator**, not a vasoconstrictor. It relaxes vascular smooth muscle via the cGMP pathway. * **Option B:** NO does not specifically target "Platelet Activating Factor-1." Its primary anti-thrombotic action is via cGMP-mediated inhibition of platelet activation and the expression of adhesion molecules (like P-selectin). * **Option C:** While NO has some modulatory effects on the autonomic nervous system, its primary physiological role in this context is vascular and hemostatic, not the inhibition of the SA node. **High-Yield Facts for NEET-PG:** * **Precursor:** NO is synthesized from the amino acid **L-arginine** by the enzyme **Nitric Oxide Synthase (NOS)**. * **Synergy:** NO works synergistically with **Prostacyclin ($PGI_2$)** to inhibit platelet aggregation. * **Clinical Correlation:** Nitroglycerin (used in Angina) works by being converted into Nitric Oxide, causing systemic vasodilation and reducing cardiac preload. * **Septic Shock:** Overproduction of NO by inducible NOS (iNOS) is a major cause of the profound vasodilation seen in septic shock.

Q: What is the Rh factor?

Protein. **Explanation:** The Rh factor (Rhesus factor) refers to a specific group of **antigens** found on the surface of red blood cells (RBCs). Chemically, these antigens are **transmembrane proteins** (specifically non-glycosylated polypeptides). The most clinically significant among them is the **D-antigen**. Individuals who possess this protein are classified as Rh-positive, while those lacking it are Rh-negative. **Why the other options are incorrect:** * **Antibody (A):** The Rh factor itself is an *antigen* (the target), not an antibody. However, Rh-negative individuals can produce anti-D antibodies (IgG) if exposed to Rh-positive blood. * **Mucopolysaccharide (B):** This describes the chemical nature of **ABO antigens**, which are oligosaccharide chains attached to a sphingolipid or protein backbone. Rh antigens differ because they are purely proteinaceous. * **Fatty acid (D):** Rh factors are structural components of the RBC membrane but are not composed of lipids or fatty acids. **Clinical Pearls for NEET-PG:** * **Inheritance:** Rh antigens are encoded by two genes, *RHD* and *RHCE*, located on **Chromosome 1**. * **Clinical Significance:** Unlike ABO antibodies, anti-Rh antibodies are not naturally occurring; they develop only after isoimmunization (e.g., mismatched transfusion or pregnancy). * **Erythroblastosis Fetalis:** This occurs when an Rh-negative mother carries an Rh-positive fetus. The resulting IgG antibodies can cross the placenta, causing hemolysis in the fetus. * **Prophylaxis:** Administering **Anti-D (RhoGAM)** to the mother at 28 weeks and within 72 hours of delivery prevents sensitization.

Q: A patient with mild congestive heart failure is treated with high-dose furosemide and diuresis of 3 liters of fluid. A complete blood count (CBC) taken before the diuresis shows an RBC count of 4 million/mm3; a CBC taken after diuresis shows an RBC count of 7 million/mm3. Which of the following is the most likely explanation?

Relative polycythemia. **Explanation:** The correct answer is **Relative polycythemia**. **1. Why it is correct:** Polycythemia is defined as an increase in the concentration of red blood cells (RBCs). It is classified into two types: **Absolute** (increase in total RBC mass) and **Relative** (decrease in plasma volume). In this clinical scenario, the patient underwent aggressive diuresis (3 liters of fluid loss). This rapid loss of intravascular fluid leads to **hemoconcentration**. Since the plasma volume decreases while the total number of RBCs remains constant, the *measured concentration* of RBCs per mm³ appears elevated (from 4 million to 7 million). This is a classic example of relative polycythemia (also known as Gaisböck syndrome in chronic cases). **2. Why the other options are incorrect:** * **A & B (Cyanotic heart disease / Increased EPO):** These conditions cause **Secondary Absolute Polycythemia**. Chronic hypoxia triggers the kidneys to release Erythropoietin (EPO), stimulating the bone marrow to produce *more* RBCs. This process takes weeks; it cannot happen acutely within the timeframe of a diuretic treatment. * **C (Polycythemia vera):** This is a **Primary Absolute Polycythemia**, a myeloproliferative neoplasm where the bone marrow produces excess RBCs independent of EPO levels. It is a chronic condition and would not be triggered by fluid loss. **3. High-Yield Clinical Pearls for NEET-PG:** * **Formula:** Hematocrit ≈ (RBC Mass) / (Plasma Volume). If Plasma Volume ↓, Hematocrit ↑ (Relative Polycythemia). * **Common causes of Relative Polycythemia:** Dehydration, severe vomiting/diarrhea, burns, and excessive use of diuretics. * **Key Distinguisher:** In relative polycythemia, the **Total RBC Mass is normal**, whereas in absolute polycythemia, the **Total RBC Mass is increased**.

Q: What is the normal range for prothrombin time?

10-20 seconds. **Explanation:** **Prothrombin Time (PT)** is a screening test used to evaluate the **Extrinsic and Common pathways** of the coagulation cascade. It specifically measures the time taken for plasma to clot after the addition of Tissue Factor (Thromboplastin) and Calcium. 1. **Why Option B is correct:** The standard normal range for PT is typically **10 to 14 seconds** (extending up to 20 seconds depending on the laboratory reagents used). It reflects the activity of clotting factors **I (Fibrinogen), II (Prothrombin), V, VII, and X**. Since Factor VII has the shortest half-life, PT is the most sensitive indicator of Vitamin K deficiency and early liver dysfunction. 2. **Why other options are incorrect:** * **Option A (5-7 seconds):** This is too rapid; blood requires a sequence of enzymatic activations that take longer than 7 seconds. * **Option C (30 seconds):** This is significantly prolonged. A PT of 30 seconds suggests severe coagulopathy, such as advanced cirrhosis or warfarin overdose. Note: 25–40 seconds is the normal range for **aPTT** (Activated Partial Thromboplastin Time). * **Option D (1 minute):** This represents a critical clinical value indicating a high risk of spontaneous hemorrhage. **High-Yield Clinical Pearls for NEET-PG:** * **INR (International Normalized Ratio):** Since PT varies by lab, INR is used to standardize results, especially for monitoring **Warfarin** therapy. (Normal INR ≈ 1.0). * **Vitamin K Dependency:** PT monitors factors II, VII, IX, and X. However, it does *not* measure Factor IX (Intrinsic pathway). * **Mnemonic:** **PeT** (PT) has 2 letters = Extrinsic pathway; **aPTT** has 4 letters = Intrinsic pathway. * **Prolonged PT only:** Suggests Factor VII deficiency. * **Prolonged PT and aPTT:** Suggests Common pathway deficiency (Factors X, V, II, I) or severe liver disease.

Q: Prostacyclin is mainly produced by?

Vascular endothelium. **Explanation:** **1. Why Vascular Endothelium is Correct:** Prostacyclin (also known as **PGI2**) is a member of the eicosanoid family of lipid mediators. It is synthesized primarily by the **vascular endothelial cells** through the action of the enzyme cyclooxygenase (COX) and prostacyclin synthase. Its primary physiological roles are **potent vasodilation** and **inhibition of platelet aggregation**. By preventing platelets from adhering to healthy vessel walls, PGI2 maintains blood fluidity and prevents intravascular clot formation. **2. Why Other Options are Incorrect:** * **Platelets:** These cells primarily produce **Thromboxane A2 (TXA2)**. TXA2 is the functional antagonist to PGI2; it promotes platelet aggregation and causes vasoconstriction. The balance between endothelial PGI2 and platelet TXA2 is crucial for hemostasis. * **Prostate:** Despite the name "prostaglandin" (originally discovered in seminal fluid), the prostate is not the primary source of PGI2. It secretes other prostaglandins (like PGE2) and enzymes like PSA. * **Testis:** While the testes produce various steroid hormones (testosterone) and local signaling molecules, they are not a significant source of systemic prostacyclin. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Mechanism of Action:** PGI2 acts by increasing intracellular **cAMP** levels in platelets, which inhibits their activation. * **Aspirin Paradox:** Low-dose aspirin irreversibly inhibits COX-1 in platelets (reducing TXA2). Since platelets lack a nucleus, they cannot regenerate the enzyme. Endothelial cells, however, can synthesize new COX, allowing PGI2 production to recover, leading to a net antithrombotic effect. * **Pharmacology:** **Epoprostenol** is a synthetic analog of PGI2 used clinically to treat Pulmonary Arterial Hypertension (PAH). * **Opposing Effects:** Remember the mnemonic: **P**GI2 **P**revents aggregation; **T**XA2 **T**riggers aggregation.

Q: Hematocrit relates to which of the following?

Total RBC volume. **Explanation:** **Hematocrit (Hct)**, also known as **Packed Cell Volume (PCV)**, is defined as the percentage of the total blood volume that is occupied by red blood cells (RBCs). When a blood sample is centrifuged, the heavier cells settle at the bottom. Since RBCs constitute approximately 99% of the cellular elements in blood, the PCV is a direct reflection of the **Total RBC volume**. * **Why Option B is correct:** Hematocrit specifically measures the volume of erythrocytes relative to the whole blood. In a healthy adult, this is approximately 45% (40-50% in males; 38-45% in females). * **Why Option A is incorrect:** Total blood volume includes both the cellular components (RBCs, WBCs, Platelets) and the plasma. Hematocrit is a *ratio* or *percentage* of this volume, not the volume itself. * **Why Option C is incorrect:** WBCs and platelets form a very thin layer between the plasma and RBCs called the **"Buffy Coat"** (usually <1% of total volume). * **Why Option D is incorrect:** Plasma filtrate refers to the fluid that passes through capillary walls into the interstitial space; it is not measured by hematocrit. **High-Yield Clinical Pearls for NEET-PG:** 1. **Wintrobe’s Tube:** The standard instrument used to determine PCV. 2. **Rule of Three:** In a normal individual, Hemoglobin (g/dL) × 3 ≈ Hematocrit (%). 3. **Clinical Variations:** * **Increased Hct:** Seen in Polycythemia and **Dehydration** (due to hemoconcentration). * **Decreased Hct:** Seen in Anemia and Pregnancy (due to hemodilution, as plasma volume increases more than RBC mass). 4. **Body Hematocrit vs. Venous Hematocrit:** The "Body Hematocrit" (average Hct of all vessels) is usually slightly lower (about 91%) than the "Venous Hematocrit" measured from a peripheral vein.

Q: Which of the following is the major site of erythropoietin production during the fetal stage?

Liver. **Explanation:** The production of **Erythropoietin (EPO)**, the primary hormone regulating red blood cell production, undergoes a significant site transition during development. 1. **Why Liver is Correct:** During the **fetal stage**, the **liver** is the primary source of erythropoietin (approximately 80-90%). While the kidneys begin producing EPO toward the end of gestation, the liver remains the dominant site until shortly after birth, when the production site shifts to the peritubular interstitial cells of the renal cortex. 2. **Why Other Options are Incorrect:** * **Yolk sac:** This is the site of the first wave of hematopoiesis (mesoblastic stage), but it does not serve as the primary site for EPO production. * **Bone (Bone Marrow):** While the bone marrow is the primary site of *erythropoiesis* (RBC production) from the 5th month of gestation onwards, it is not a site for EPO *synthesis*. * **Spleen:** The spleen is an extramedullary hematopoietic organ during the fetal period (hepatic stage), but its contribution to EPO production is negligible compared to the liver. **High-Yield Clinical Pearls for NEET-PG:** * **Adult Site:** In adults, **90%** of EPO is produced by the **Kidneys** (Peritubular interstitial cells) and 10% by the Liver. * **Stimulus:** The primary stimulus for EPO release is **hypoxia** (detected by HIF-1α). * **Fetal vs. Adult:** The fetal liver is less sensitive to hypoxia than the adult kidney, which is one reason why fetal erythropoiesis is maintained at a steady rate. * **Chronic Kidney Disease (CKD):** Anemia in CKD is primarily due to the loss of EPO-producing cells in the kidney.

Question 1

Neonatal thymectomy leads to what immunological change?

Accepted Answer

Decreased size of paracortical areas

Answer

Decreased size of germinal centers

Answer

Increased antibody production

Answer

Increased bone marrow production of lymphocytes

Question 2

Which of the following is likely to be increased in vitamin K deficiency?

Accepted Answer

PT

Answer

PTT

Answer

Platelet count

Answer

Fibrinogen time

Question 3

Regarding hemostasis, what is the true statement for nitric oxide?

Accepted Answer

Inhibits platelet aggregation

Answer

Is a vasoconstrictor

Answer

Inhibits platelet activating factor-1

Answer

Inhibits Sinoatrial node

Question 4

What is the Rh factor?

Accepted Answer

Protein

Answer

Antibody

Answer

Mucopolysaccharide

Answer

Fatty acid

Question 5

A patient with mild congestive heart failure is treated with high-dose furosemide and diuresis of 3 liters of fluid. A complete blood count (CBC) taken before the diuresis shows an RBC count of 4 million/mm3; a CBC taken after diuresis shows an RBC count of 7 million/mm3. Which of the following is the most likely explanation?

Accepted Answer

Relative polycythemia

Answer

Cyanotic heart disease

Answer

Increased erythropoietin

Answer

Polycythemia vera

Question 6

What is the normal range for prothrombin time?

Accepted Answer

10-20 seconds

Answer

5-7 seconds

Answer

30 seconds

Answer

1 minute

Question 7

Prostacyclin is mainly produced by?

Accepted Answer

Vascular endothelium

Answer

Platelet

Answer

Prostate

Answer

Testis

Question 8

Hematocrit relates to which of the following?

Accepted Answer

Total RBC volume

Answer

Total blood volume

Answer

Total WBC volume

Answer

Plasma filtrate

Question 9

Which of the following is the major site of erythropoietin production during the fetal stage?

Accepted Answer

Liver

Answer

Yolk sac

Answer

Bone

Answer

Spleen

Question 10

A man weighing 70 kg has a hematocrit of 45%. What is his approximate plasma volume?

Accepted Answer

3080 mL

Answer

2310 mL

Answer

2695 mL

Answer

2890 mL

Blood and Immunity — MCQs

Blood and Immunity — MCQs

On this page

Practice by Chapter

Want unlimited practice?